The Editorial Board of the Proceedings of the National Academy of Sciences (PNAS) has selected six papers published by PNAS in 2025 to receive the Cozzarelli Prize, an award that recognizes ...

An informational industry analysis examining ingredient-level research, marketing positioning trends, regulatory context, and ...

IO@MBD combines ?-Fe2O3 nanoparticles and melamine dendrimers, creating a stable, pH-responsive platform for effective doxorubicin delivery in cancer treatment.

Amid an explosion of aging research, there are plenty of “biohackers” out there jumping the gun without waiting for proof of efficacy.

Anbio Biotechnology continues pivoting toward better profitability metrics, prioritized high-margin orders over sales volume. Read more on NNNN stock here.